EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial

Laurel H Messer iD, Colleen Bauza iD, Kellee M Miller, Mark A Clements, Daniel J DeSalvo, Jennifer Sherr, Ruth S Weinstock, Korey Hood, Lori M Laffel

Pediatric Diabetes · 15.09.2023 · 2023 · 1-10

DOI: 10.1155/2023/6906023 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Diabetes, erschienen am 15.09.2023. Verfasst von Laurel H Messer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus (now with Tandem Diabetes Care), Aurora, CO, USA. Hauptthemen laut MEDLINE: Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leona M. and Harry B. Helmsley Charitable Trust, Jaeb Center for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate patterns of continuous glucose monitor (CGM) use and perceptions of quality of life in adolescents/young adults with type 1 diabetes (T1D) after using CGM for up to 52 weeks in the CGM Intervention in Teens and Young (CITY) Adults randomized clinical trial (RCT). Subjects and Methods. Participants with T1D were initially randomized 1 : 1 to use of CGM or blood glucose meter (BGM) for 26 weeks. Following the RCT, participants in the BGM group initiated CGM (BGM–CGM cohort) and participants in the CGM group continued CGM (CGM–CGM cohort) for another 26 weeks. Problem Areas in Diabetes Survey-Pediatric Version (PAID-peds), Glucose Monitoring Satisfaction Survey (GMSS), Hypoglycemia Confidence Scale (HCS), Diabetes Technology Attitudes (DTA), Pittsburgh Sleep Quality Index (PSQI), Benefits of CGM, and Burdens of CGM were completed at baseline, 26 and 52 weeks.

Results

In both cohorts, >70% of participants were wearing CGM > 5 days/week at 52 weeks; 5% discontinued CGM. The majority used the mobile app to receive glucose data. Adolescents (14 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Glucose Self-MonitoringDiabetes Mellitus, Type 1HumansAdolescentMaleFemaleYoung AdultQuality of LifeBlood GlucosePatient Reported Outcome MeasuresPatient SatisfactionContinuous Glucose Monitoring

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus (now with Tandem Diabetes Care), Aurora, CO, USA.
  • Jaeb Center for Health Research, Tampa, FL, USA.
  • T1D Exchange, St. Petersburg, FL, USA.
  • Children's Mercy Hospital, Kansas City, MO, USA.
  • Baylor College of Medicine, Houston, TX, USA.
  • Yale School of Medicine, New Haven, CT, USA.

ORCID-Profile: Laurel H Messer, Colleen Bauza

Förderung

  • Leona M. and Harry B. Helmsley Charitable Trust
  • Jaeb Center for Health Research

Zitieren

APA

Messer, L. H., Bauza, C., Miller, K. M., Clements, M. A., DeSalvo, D. J., Sherr, J., Weinstock, R. S., Hood, K., & Laffel, L. M. (2023). Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial. Pediatric Diabetes, 2023, 1-10. https://doi.org/10.1155/2023/6906023

Vancouver

Messer LH, Bauza C, Miller KM, Clements MA, DeSalvo DJ, Sherr J, et al. Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial. Pediatric Diabetes. 2023;2023:1-10. doi:10.1155/2023/6906023

BibTeX
@article{Messer2023,
  author = {Messer, Laurel H and Bauza, Colleen and Miller, Kellee M and Clements, Mark A and DeSalvo, Daniel J and Sherr, Jennifer and Weinstock, Ruth S and Hood, Korey and Laffel, Lori M},
  title = {Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial},
  journal = {Pediatric Diabetes},
  year = {2023},
  volume = {2023},
  pages = {1--10},
  doi = {10.1155/2023/6906023}
}
Kostenlos starten →